Clinical Trial Update: An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis

View source ↗

Summary

An observational prospective long-term exposure registry sponsored by Janssen Biotech to monitor safety and real-world use in adults with moderate-to-severe ulc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Janssen Biotech, Inc. | Conditions: Ulcerative Colitis | Status: ACTIVE_NOT_RECRUITING